核酸样品製备市场－全球产业规模、份额、趋势、机会及预测，依产品、技术、治疗领域、应用、最终用户、地区及竞争细分，2020-2030 年预测

2024 年全球核酸样品製备市场价值为 26.5 亿美元，预计到 2030 年将达到 38.6 亿美元，预测期内复合年增长率为 6.45%。该市场透过实现从各种生物来源中高效提取、纯化和製备 DNA 和 RNA，在生命科学和诊断行业中发挥着至关重要的作用。分子诊断应用的日益增多、基因组研究的扩展以及全球向个人化医疗的转变推动了市场的成长。随着世界各地的实验室对更有效率、可扩展的工作流程的需求，各公司正在投资自动化、创新和策略合作，以提供满足临床和研究环境需求的高通量解决方案。

关键市场驱动因素

核酸检测在传染病管理的应用增加

主要市场挑战

先进样品製备技术成本高

主要市场趋势

自动化与高通量系统的集成

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：核酸样品製备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（耗材、系统、配件和组件）
  • 依技术分类（基于旋转柱的技术、基于磁珠的技术、其他技术）
  • 依治疗领域（肿瘤学、传染病、人类遗传学/群体遗传学、其他）
  • 按应用（基因体学、蛋白质体学、其他）
  • 按最终用户（学术和研究机构、製药和生物技术公司、临床和诊断实验室、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美核酸样品製备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲核酸样品製备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区核酸样品製备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美核酸样品製备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲核酸样品製备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第十三章：全球核酸样品製备市场：SWOT分析

第 14 章：竞争格局

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Nucleic Acid Sample Preparation Market was valued at USD 2.65 Billion in 2024 and is projected to reach USD 3.86 Billion by 2030, growing at a CAGR of 6.45% during the forecast period. This market plays a vital role in the life sciences and diagnostics industry by enabling the efficient extraction, purification, and preparation of DNA and RNA from various biological sources. Market growth is fueled by the increasing application of molecular diagnostics, the expansion of genomic research, and the global shift toward personalized medicine. As laboratories worldwide demand more efficient and scalable workflows, companies are investing in automation, innovation, and strategic collaborations to deliver high-throughput solutions that address the needs of both clinical and research environments.

Key Market Drivers

Increased Use of Nucleic Acid Testing in Infectious Disease Management

The expanding use of nucleic acid-based testing for infectious disease management is a primary growth driver in the market. Nucleic acid tests (NATs), including RT-PCR, are now central to disease surveillance and diagnostics due to their sensitivity and accuracy. This shift from traditional diagnostic techniques has increased demand for reliable nucleic acid preparation products. According to data from the Institute for Health Metrics and Evaluation, 85 pathogens were responsible for 704 million disability-adjusted life years (DALYs) in 2019, highlighting the vast global disease burden and the urgent need for precise molecular diagnostics. During the COVID-19 pandemic, the importance of rapid viral RNA extraction was underscored, leading to a global uptick in demand for sample preparation kits and systems. This growing reliance on NATs in public health, hospital labs, and point-of-care settings continues to propel market demand for advanced sample prep technologies.

Key Market Challenges

High Cost of Advanced Sample Preparation Technologies

One of the core challenges in this market is the high cost associated with advanced nucleic acid preparation technologies. Automated systems, next-generation sequencing (NGS) compatible platforms, and specialized consumables can impose significant financial burdens on laboratories. These costs hinder the widespread adoption of such technologies, especially in low- and middle-income countries where healthcare budgets are limited. As a result, many laboratories may opt for manual or lower-cost alternatives, restricting the market's reach and delaying the broader implementation of molecular diagnostics and precision medicine.

Key Market Trends

Integration of Automation and High-Throughput Systems

The integration of automation and high-throughput technologies is a defining trend within the nucleic acid sample preparation market. Automated systems streamline complex workflows, increase throughput, and reduce human error, making them essential in clinical diagnostics and research applications. These platforms, often powered by robotics and AI-driven software, enable laboratories to handle larger volumes of samples efficiently. Automation also enhances reproducibility and consistency in results, which is vital for applications in genomics, infectious disease testing, and precision medicine. As the cost of automation technology becomes more accessible, its adoption is expected to rise significantly across a range of laboratory settings.

Key Market Players

• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.

Report Scope:

In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Sample Preparation Market, By Product:

• Consumables
• Systems
• Accessories & Components

Nucleic Acid Sample Preparation Market, By Technology:

• Spin-Column Based Technology
• Magnetic-Bead Based Technology
• Others

Nucleic Acid Sample Preparation Market, By Therapeutics Area:

• Oncology
• Infectious Disease
• Human Genetics/Population Genetics
• Others

Nucleic Acid Sample Preparation Market, By Application:

• Genomics
• Proteomics
• Others

Nucleic Acid Sample Preparation Market, By End User:

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Other

Nucleic Acid Sample Preparation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.

Available Customizations:

Global Nucleic Acid Sample Preparation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Nucleic Acid Sample Preparation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Systems, Accessories & Components)
  • 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
  • 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
  • 5.2.4. By Application (Genomics, Proteomics, Others)
  • 5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Nucleic Acid Sample Preparation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Therapeutics Area
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Therapeutics Area
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Therapeutics Area
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Therapeutics Area
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Nucleic Acid Sample Preparation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Therapeutics Area
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Therapeutics Area
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Nucleic Acid Sample Preparation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Therapeutics Area
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Nucleic Acid Sample Preparation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Therapeutics Area
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Nucleic Acid Sample Preparation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Therapeutics Area
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Therapeutics Area
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Therapeutics Area
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Nucleic Acid Sample Preparation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Therapeutics Area
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Nucleic Acid Sample Preparation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Therapeutics Area
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Therapeutics Area
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Therapeutics Area
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Therapeutics Area
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Nucleic Acid Sample Preparation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Therapeutics Area
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Therapeutics Area
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Therapeutics Area
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Therapeutics Area
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Therapeutics Area
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Therapeutics Area
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Therapeutics Area
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Therapeutics Area
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis

14. Competitive Landscape

• 14.1. BGI Group
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. F. Hoffmann-La Roche Ltd
• 14.3. Danaher Corporation
• 14.4. Eppendorf SE
• 14.5. BIONEER CORPORATION
• 14.6. Endress+Hauser Group Services AG
• 14.7. Merck KGaA
• 14.8. Norgen Biotek Corp.
• 14.9. Aurora Biomed Inc.
• 14.10.Agilent Technologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer